Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Axon loss in multiple sclerosis

N Scolding1, R Franklin

  • 1University of Cambridge Neurology Unit, Addenbrooke's Hospital, UK.

Lancet (London, England)
|August 26, 1998
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unveiling the Mysteries of Ameloblastoma: A Comprehensive Case Series on Odontogenic Lesions.

Journal of pharmacy & bioallied sciences·2025
Same author

Salivary duct carcinoma in the submandibular gland: A rare case report with differential diagnosis.

Journal of oral and maxillofacial pathology : JOMFP·2024
Same author

Anti-cancer effects of green synthesized gold nanoparticles using leaf extract of <i>Annona muricata</i>. L against squamous cell carcinoma cell line 15 through apoptotic pathway.

Dental research journal·2024
Same author

Evaluation of the cytotoxic, anti-proliferative, anti-metastatic and pro-apoptotic effect of aqueous leaf extract of <i>Annona muricata</i> on oral tongue squamous cell carcinoma cell line (SCC-15): An <i>in vitro</i> study.

Journal of oral and maxillofacial pathology : JOMFP·2023
Same author

LP2, a stable lanthipeptide derived from cAng-(1-7), exerts myeloprotective action in mice.

European journal of haematology·2023
Same author

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Journal of neurology·2021
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
See all related articles